AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Initial chemotherapy beneficial in epithelial ovarian cancer.(News)

OB GYN News

| March 01, 2006 | Lowry, Fran | COPYRIGHT 2006 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

ORLANDO -- Chemotherapy that is given before surgery improves optimal cytoreduction rates in patients with advanced epithelial ovarian cancer, a retrospective comparative study suggests.

Most women with advanced epithelial ovarian cancer receive initial surgery followed by intensive platinum/taxane combination chemotherapy.

The goal is optimal cytoreduction ("debulking") defined as gross residual disease of less than 1 cm following maximal surgical effort, but this goal is only achieved about half of the time.

Patients were selected for initial chemotherapy based upon disease extent estimated on preoperative CT scan or unacceptable medical comorbidities.

Initial chemotherapy was given to patients with disease judged unlikely to achieve an optimal result with resection.

In addition, patients medically unfit for surgery or patients who refused surgery secondary to the risks of transfusion or ostomy were given initial chemotherapy. Rates of hemorrhage, bowel resection, and postoperative surgical morbidity were similar in the two groups, as were chemotherapy regimens, Dr. Elise Everett said at the annual meeting of the South Atlantic Association of Obstetricians and Gynecologists.

The rate of optimal debulking was 85% in 98 advanced epithelial ovarian cancer patients who received initial chemotherapy prior to their surgery, ...

Related articles from newspapers, magazines, journals, and more
Investigational drug shows promise in ovarian cancer.
Newspaper article from: Clinical Trials Week September 29, 2008 700+ words
...drug that combats ovarian cancer by inhibiting the...Many patients with ovarian cancer will have a recurrence of cancer following initial chemotherapy," he said. "This...women with recurrent ovarian cancer." The findings...
NICE Recommends Caelyx(R) For Newly-Recognised Group of Advanced Ovarian Cancer...
Press release article from: PR Newswire Europe May 24, 2005 700+ words
...treatment of advanced ovarian cancer[i]. The guidance...platinum-sensitive ovarian cancer patients - those...treatment for women with ovarian cancer who relapse between 6 and 12 months after initial chemotherapy. It affords clinicians...
Genome Research May Help Predict Success of Ovarian Cancer Chemotherapy.
Press release article from: PR Newswire March 19, 2002 700+ words
...the SGO meeting. "Ovarian cancer is difficult to eradicate...women diagnosed with ovarian cancer." Using molecular...that responded to initial chemotherapy were compared to...sample sets from ovarian cancer patients who have...
Platinum-Paclitaxel As Second-Line Chemotherapy for Relapsed Ovarian...
Newspaper article from: Clinical Oncology Alert August 1, 2003 700+ words
...chemotherapy for ovarian cancer, most patients...DFI) after initial chemotherapy. The standard...recurrent ovarian cancer and were...DFI after initial chemotherapy. All patients...epithelial ovarian cancer requiring...
OvaRex MAb for Patients with Advanced Ovarian Cancer May Extend Remission...
Press release article from: Business Wire February 17, 2005 700+ words
...patients with advanced ovarian cancer, the current standard...with stage III or IV ovarian cancer, who qualify to...their last dose of initial chemotherapy. For more information...Society (ACS), ovarian cancer causes more deaths...
BRISTOL MYERS-SQUIBB: THREE NEW STUDIES SHOW TAXOL(R)(paclitaxel) COMBINATION...
Press release article from: PR Newswire May 20, 1996 700+ words
...with newly diagnosed ovarian cancer who were treated...women with advanced ovarian cancer extended their median...containing compound as initial chemotherapy. This large study...survival for advanced ovarian cancer patients. TAXOL...
Results of Interval Debulking Surgery Compared with Primary Debulking Surgery...
Magazine article from: OB/GYN Clinical Alert March 1, 2004 700+ words
...advanced-stage ovarian cancer. Source: Morice...approach to advanced ovarian cancer management, Morice...surgery. Following the initial chemotherapy, tumor reduction...unresectable advanced ovarian cancer and is associated...
Results of Interval Debulking Surgery Compared with Primary Debulking Surgery...
Newspaper article from: Clinical Oncology Alert April 1, 2004 700+ words
...advanced-stage ovarian cancer. Source: Morice...approach to advanced ovarian cancer management, Morice...surgery. Following the initial chemotherapy, tumor reduction...unresectable advanced ovarian cancer and is associated...
For more facts and information, see all results

Source: HighBeam Research, Initial chemotherapy beneficial in epithelial ovarian cancer.(News)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA